iPhone | iPad
Android
Huawei
Authorities called on all individuals to download the UAEICP application and benefit from the varied services offered
KT APPDOWNLOAD
Merck anti-Covid pill molnupiravir to be produced by 27 drugmakers
The agreement, negotiated by the MPP with Merck, allows 27 generic drugmakers to produce ingredients and the finished drug.
Reuters file
Nearly 30 generic drugs manufacturers signed an agreement to produce low-cost versions of Merck & Co's Covid-19 pill molnupiravir, the UN-backed Medicines Patent Pool (MPP) said on Thursday.
The agreement, negotiated by the MPP with Merck, allows 27 generic drugmakers from India, China and other countries in Africa, Asia and the Middle East to produce ingredients and the finished drug.
The MPP said that deal stipulates that the pill will be distributed to 105 less-developed nations. The developers of molnupiravir, which alongside Merck are US firm Ridgeback Biotherapeutics and Emory University, will not receive royalties for the sale of its low-cost version produced by generic drugmakers.
ALSO READ:
"This is a critical step towards ensuring global access to an urgently needed Covid-19 treatment and we are confident that, as manufacturers are working closely with regulatory authorities, the anticipated treatments will be rapidly available," said MPP Executive Director Charles Gore.
More news from
Uncertainty about the future, specifically uncertainty about survival, influences human behaviour and practical life-course decision-making
Conceived by the late Okwui Enwezor and curated by Hoor Al Qasimi, the Sharjah Biennial runs from February 7 through June 11
Dutch researcher goes viral after predicting devastating Turkey earthquake 3 days before it happened
Some flagged him on Twitter as a pseudo-scientist and questioned his earlier predictions
22 agreements commit government teams to ensure the timely development of 80 transformational projects over the next six months
In talks this week, European trade representatives are expected to tell senior US officials not to try to actively poach green investment from Europe as they again raise concerns about subsidies.
To be sure, bad actors could abuse these tools for various illicit schemes, such as sophisticated online scams or writing malware. But the technology’s prospective applications, from coding to protein discovery, offer cause for optimism
Foreseeing the future and taking risks is in the DNA of this country, says Dubai Future Foundation CEO